RxDoctor Payments Data
★ My doctorsLook up a doctor →

Benjamin Zaremski

Cardiovascular Disease · New York, NYNPI 1912080524

Payments from drug & device makers

$3,931in general payments, 2019–2025

Across 179 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$846
  • Biotronik Inc.$558
  • Johnson & Johnson$535
  • Amgen$390
  • AstraZeneca$317
  • Novartis$306
  • plus $980 from 13 others

What the payments were for

  • Food & beverage$3,59892%
  • Education$3338%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim46$846
Biotronik Inc.10$558
Johnson & Johnson20$535
Amgen18$390
AstraZeneca17$317
Novartis15$306
Amarin Pharma, Inc.16$217
Pfizer10$206
Novo Nordisk6$109
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$108
Takeda Pharmaceuticals U.S.A., Inc.4$94
E.r. Squibb & Sons, L.L.C.3$70
Edwards Lifesciences2$40
Esperion Therapeutics, Inc.1$30
Regeneron Healthcare Solutions, Inc.1$28
Daiichi Sankyo Inc.1$25
Sanofi-aventis U.S. LLC1$25
Metuchen Pharmaceuticals1$17
Merck1$13

How this compares

$3,931 in reported general payments places this provider in the 65th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Other cardiovascular disease in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →